Amarin Corp Plc (AMRN)

[jomama9231]

You make a good point. It can still stand. However, the way she arrived at her conclusion was flawed. Her conclusions on Mori are also flawed and her use of an irrelevant study Kurabayashi to support Mori was ridiculous. That was a study of EpA and estriol vs estriol alone in menopausal women with TG levels around 150. No true control and no men. Not relevant to our qs of pts with Tg>500. I think the federal court needs to realize these flaws and a few of them together get us a win on appeal. It can’t just be the procedural error she made (unless the fed court rules that when they weigh the evidence in the secondary considerations against primary it was enough to rule in our favor)